Brightlands Venture Partners

Mane Biotech is a venture-funded startup making hair loss prevention and hair regrowth possible by using regenerative medicine. The human body displays remarkable abilities to heal and regenerate due to the function of adult stem cells. At Mane Biotech, we are unlocking the body's regeneration potential to grow hair. We are developing a smart, wearable device to regrow hair and stop hair loss in people with Androgenetic Alopecia.

Operator of an online recipe platform intended to create a fully personalized user experience. The company's application offers recipes based on customer, needs and lifestyle preferences, its recipe ad tech facilitates automatically take-up food brands in online recipe content and it helps users to set up a personal food profile, including highly-specific dietary needs, enabling users to convert a recipe into a plant-based or gluten-free version.

Neuroplast B.V., founded in 2013 and based in Geleen, the Netherlands, operates a stem cell manufacturing laboratory specializing in the development of low immunogenic stem cells. These innovative stem cells aim to provide therapeutic solutions for patients afflicted with neurodegenerative diseases. The company is positioned within the field of neuro-regenerative personalized medicine, which is recognized as a promising area of therapy requiring consistent standards and regulations to ensure effective treatment outcomes.

Qorium is a biotech company that provides premium, cell-cultured collagen-based leather.

Black Bear Carbon BV specializes in converting waste tires into carbon black and green energy, operating primarily in the Netherlands and internationally. Founded in 2010 and based in Nederweert, the company utilizes a circular economy model to transform end-of-life tires into sustainable products. Its carbon black, a form of elemental carbon produced through controlled pyrolysis and partial combustion, is employed in various applications, including tires, technical rubber products, plastics, and paints. Additionally, Black Bear Carbon powers its tire shredding operations with electricity generated on-site, while also supplying excess energy to local industries and grids. By providing a renewable resource that reduces reliance on oil and lowers carbon dioxide emissions, the company promotes environmentally friendly practices in the manufacturing sector.

Neuroplast B.V., founded in 2013 and based in Geleen, the Netherlands, operates a stem cell manufacturing laboratory specializing in the development of low immunogenic stem cells. These innovative stem cells aim to provide therapeutic solutions for patients afflicted with neurodegenerative diseases. The company is positioned within the field of neuro-regenerative personalized medicine, which is recognized as a promising area of therapy requiring consistent standards and regulations to ensure effective treatment outcomes.

Developer of machines and autonomous asparagus harvesting robots designed to automate the harvesting of labor-intensive crops. The company's robots include special machines for the food industry and bring industrial automation to the agricultural industry, which can also be used for customer-based specials, enabling clients to harvest white asparagus and making labor reduction and process optimization accessible to small and medium-sized enterprises.

Vacis B.V. is a tissue engineering company based in Geleen, the Netherlands, founded in 2016. The company specializes in developing in situ tissue-engineered blood vessels aimed at improving vascular access for patients undergoing hemodialysis. Vacis's innovative technology involves the use of a synthetic rod that is implanted under the skin, prompting the body to generate a tissue capsule that matures into a functional blood vessel. This approach allows for the creation of autologous graft vessels, which offer enhanced patency and a reduced risk of complications compared to traditional prosthetic grafts. By providing novel therapeutic solutions for vascular surgery, Vacis addresses significant challenges in the field, including the frequent failure of prosthetic vascular grafts, thereby potentially lowering healthcare costs and improving patient outcomes.

Grassa B.V., founded in 2014 and based in Venlo, Netherlands, specializes in the bio-refining of grass and vegetable waste to create high-quality animal feed and protein supplements. The company utilizes mobile refining machines to process various green residuals, including fresh grass, agricultural by-products, invasive aquatic plants, and natural grass from conservation areas. This innovative approach results in the extraction of valuable products such as fibers, proteins, phosphates, and a liquid by-product known as "whey." By enhancing the value of these plant materials, Grassa supports farmers in addressing food scarcity while providing them with sustainable income opportunities.

Hy2Care BV is a business start-up of the University of Twente, the Netherlands. It is Hy2Care’s ambition to introduce into the market the first cure for Osteoarthritis, the injectable hydrogel. Osteoarthritis is the 4th leading cause of mobility associated disability and affects more than 100 million patients in the Western world, who are all in need for an effective treatment. It is the aim of Hy2Care to change the future for patients suffering from osteoarthritis.